NCT01326338

Nitazoxanide for the Treatment of Prolonged Diarrhea in Children

Multi-Center, Double-Blind, Placebo-Controlled Study of Nitazoxanide Suspension in the Treatment of Prolonged Diarrhea in Children

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Romark Laboratories L.C. · Industry
• Sex: All
• Age: 12 Months – 11 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to determine the efficacy of nitazoxanide suspension compared to placebo in treating prolonged diarrhea in children.

Conditions

• Diarrhea

Interventions

Type	Name	Description
DRUG	Nitazoxanide	Nitazoxanide Oral Suspension 100 mg/5 ml for patients aged 1-3 years twice daily for 3 days or Nitazoxanide Oral Suspension 200 mg/10 ml for patients aged 4-11 years twice daily for 3 days

Timeline

• Start date: 2005-03-01
• Primary completion: 2006-05-01
• Completion: 2006-05-01
• First posted: 2011-03-30
• Last updated: 2011-03-30

Locations

1 site across 1 country: Peru